Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc

$ 3.58 +0.05 (+1.42%) 11:08 PM EST
P/E:
At Loss
P/B:
0.37
Market Cap:
$ 6.43M
Enterprise V:
$ 1.68M
Volume:
86.20K
Avg Vol (2M):
283.52K
Also Trade In:
Volume:
86.20K
Market Cap $:
6.43M
PE Ratio:
At Loss
Avg Vol (2-Month):
283.52K
Enterprise Value $:
1.68M
PB Ratio:
0.37

Business Description

Description
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The products pipeline of the company includes KIO-101, KIO-201, KIO-301, and KIO-102.
Name Current Vs Industry Vs History
Cash-To-Debt 35.31
Equity-to-Asset 0.6
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.72
9-Day RSI 48.52
14-Day RSI 48.75
6-1 Month Momentum % -42.53
12-1 Month Momentum % -88.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.21
Quick Ratio 2.21
Cash Ratio 1.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -63.1
Name Current Vs Industry Vs History
ROE % -138.21
ROA % -89.57
ROIC % -84.43
ROC (Joel Greenblatt) % -5803.02
ROCE % -88.79
Name Current Vs Industry Vs History
PB Ratio 0.37
EV-to-EBIT -0.11
EV-to-EBITDA -0.11
EV-to-FCF -0.15
Earnings Yield (Greenblatt) % -909.09